Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome-Reference-Cited by-同舟云学术

Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Published:2013-03-05 Issue:12 Volume:84 Page:1346-1348
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Sekiguchi Yukari,Misawa Sonoko,Shibuya Kazumoto,Nasu Saiko,Mitsuma Satsuki,Iwai Yuta,Beppu Minako,Sawai Setsu,Ito Shoichi,Hirano Shigeki,Nakaseko Chiaki,Kuwabara Satoshi

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference20 articles.

1. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome;Watanabe;Muscle Nerve,1998

2. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature;Dispenzieri;Blood,2004

3. Treatment for POEMS syndrome;Kuwabara;Cochrane Database Syst Rev,2008

4. Bevacizumab therapy for POEMS syndrome;Badros;Blood,2005

5. Bevacizumab therapy for POEMS syndrome (author reply);Badros;Blood,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review;Frontiers in Oncology;2024-08-01

2. Plasma cell and neutrophil enriched neovascularization with granulomatous lymphangitis in POEMS syndrome;JAAD Case Reports;2024-07

3. Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges;Journal of the Peripheral Nervous System;2024-06

4. Overview of Research Status in Castleman Disease;Clinical Lymphoma Myeloma and Leukemia;2024-06

5. „Verseny az idővel”: a POEMS szindróma;Ideggyógyászati szemle;2024